Results 171 to 180 of about 3,535 (191)

Mirabegron: A Review of Its Use in Patients With Overactive Bladder Syndrome

Drugs, 2013
Mark Sanford
exaly  

Patient-Reported Outcomes From SYNERGY, a Randomized, Double-Blind, Multicenter Study Evaluating Combinations of Mirabegron and Solifenacin Compared With Monotherapy and Placebo in OAB Patients

Neurourology and Urodynamics, 2018
Dudley Robinson, Elizabeth R Mueller, David Staskin   +2 more
exaly  

The Efficacy and Safety of Mirabegron Compared With Solifenacin in Overactive Bladder Patients Dissatisfied With Previous Antimuscarinic Treatment Due to Lack of Efficacy: Results of a Noninferiority, Randomized, Phase IIIb Trial

Therapeutic Advances in Urology, 2015
Michael J Halaska, Tomasz Rechberger, Heinz Kölbl   +2 more
exaly  

Mirabegron: A Review of Recent Data and Its Prospects in the Management of Overactive Bladder

Therapeutic Advances in Urology, 2012
Riccardo Bientinesi, Emilio Sacco
exaly  

Mirabegron/propiverine

Reactions Weekly, 2018
openaire   +1 more source

Effect of Mirabegron, a Novel β3-Adrenoceptor Agonist, on Bladder Function During Storage Phase in Rats

Naunyn-Schmiedeberg's Archives of Pharmacology, 2013
Koji Ueshima, Akiyoshi Someya, Masanori Suzuki   +2 more
exaly  

MIRABEGRON FORMULATION

2023
KAPPES SEBASTIAN KALJU, LAMPRECHT ALF, NIU ZHEMING, PFEIFER ALEXANDER   +3 more
openaire   +1 more source

Role of Cytochrome P450 Isoenzymes 3A and 2D6 in the in Vivo Metabolism of Mirabegron, a β3-Adrenoceptor Agonist

Clinical Drug Investigation, 2013
Taiji Sawamoto, Marcel van Gelderen, John Meijer   +2 more
exaly  

Consultations: Mirabegron

The Pharmaceutical Journal, 2013
openaire   +1 more source

Meta-Analysis of the Efficacy and Safety of Mirabegron and Solifenacin Monotherapy for Overactive Bladder

Neurourology and Urodynamics, 2019
Hejia Yuan, Jipeng Wang, Zhe Zhu
exaly